Adrenocortical stem and progenitor cells: Implications for cancer

Adrenocortical Carcinoma: Basic Science and Clinical Concepts

Volumn , Issue , 2011, Pages 285-304

  Heaton, Joanne H ^a   Hammer, Gary D ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865270628     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-77236-3_17     Document Type: Chapter

References (87)

1. Dick JE (2003) Breast cancer stem cells revealed. Proc Natl Acad Sci U S A 100(7):3547-3549
2. Reya T et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111
3. Dalerba P et al (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267-284
4. Lobo NA et al (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23:675-699
5. Shackleton M et al (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138(5):822-829
6. Ailles LE, Weissman IL (2007) Cancer stem cells in solid tumors. Curr Opin Biotechnol 18(5):460-466
7. Quintana E et al (2008) Efficient tumour formation by single human melanoma cells. Nature 456(7222):593-598
8. Libe R et al (2007) Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 14(1):13-28
9. Bertherat J, Bertagna X (2009) Pathogenesis of adrenocortical cancer. Best Pract Res Clin Endocrinol Metab 23(2):261-271
10. Keegan CE, Hammer GD (2002) Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol Metab 13(5):200-208
11. Kim AC, Hammer GD (2007) Adrenocortical cells with stem/progenitor cell properties: recent advances. Mol Cell Endocrinol 265-266:10-16
12. Luo X et al (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77(4):481-490
13. Sadovsky Y et al (1995) Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc Natl Acad Sci U S A 92(24):10939-10943
14. Schnabel CA et al (2003) Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 37(3):123-130
15. James RG et al (2006) Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells. Development 133(15):2995-3004
16. Katoh-Fukui Y et al (2005) Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 106(5):1612-1620
17. Val P et al (2007) Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 134(12):2349-2358
18. Zubair M et al (2006) Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol Cell Biol 26(11):4111-4121
19. Else T, Hammer GD (2005) Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol Metab 16(10):458-468
20. Beuschlein F et al (2002) Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 143(8):3122-3135
21. Pignatelli D et al (2002) Proliferation of capsular stem cells induced by ACTH in the rat adrenal cortex. Endocr Res 28(4):683-691
22. Ford JK, Young RW (1963) Cell proliferation and displacement in the adrenal cortex of young rats injected with tritiated thymidine. Anat Rec 146:125-137
23. Zubair M et al (2008) Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol Cell Biol 28(23):7030-7040
24. Ingham PW, McMahon AP (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15(23):3059-3087
25. Xie K, Abbruzzese JL (2003) Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 4(4):245-247
26. Han YG et al (2008) Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells. Nat Neurosci 11(3):277-284
27. Komada M et al (2008) Hedgehog signaling is involved in development of the neocortex. Development 135(16):2717-2727
28. King P et al (2009) Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc Natl Acad Sci U S A 106(50):21185-21190
29. Huang CC et al (2010) Progenitor Cell Expansion and Organ Size of Mouse Adrenal Is Regulated by Sonic Hedgehog. Endocrinology 151(3):1119-1128
30. Ching S, Vilain E (2009) Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 47(9):628-637
31. Muscatelli F et al (1994) Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372(6507):672-676
32. Kim AC et al (2009) In search of adrenocortical stem and progenitor cells. Endocr Rev 30(3):241-263
33. Phelan JK, McCabe ER (2001) Mutations in NR0B1(DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita. Hum Mutat 18(6):472-487
34. Zanaria E et al (1994) An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372(6507):635-641
35. Peter M et al (1998) Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J Clin Endocrinol Metab 83(8):2666-2674
36. Achermann JC et al (2000) Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1. J Pediatr 137(6):878-881
37. Babu PS et al (2002) Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 143(2):665-673
38. Gummow BM et al (2003) Convergence of Wnt signaling and steroidogenic factor-1(SF-1) on transcription of the rat inhibin alpha gene. J Biol Chem 278(29):26572-26579
39. Gummow BM et al (2006) Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol 20(11):2711-2723
40. Niakan KK et al (2006) Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol Genet Metab 88(3):261-271
41. Khalfallah O et al (2009) Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells 27(7):1529-1537
42. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810
43. Blanpain C et al (2007) Epithelial stem cells: turning over new leaves. Cell 128(3):445-458
44. Kim AC et al (2008) Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 135(15):2593-2602
45. Samani AA et al (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28(1):20-47
46. Mesiano S et al (1993) Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 76(4):968-976
47. Rainey WE et al (2002) The adrenal genetic puzzle: how do the fetal and adult pieces differ? Endocr Res 28(4):611-622
48. Bendall SC et al (2007) IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448(7157):1015-1021
49. Beuschlein F et al (1994) Clonal composition of human adrenocortical neoplasms. Cancer Res 54(18):4927-4932
50. Gicquel C et al (1994) Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) 40(4):465-477
51. Kikuchi A (2003) Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 94(3):225-229
52. Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17(1):45-51
53. Fodde R, Brabletz T (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19(2):150-158
54. Kinzler KW et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253(5020):661-665
55. Groden J et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66(3):589-600
56. Fearnhead NS et al (2001) The ABC of APC. Hum Mol Genet 10(7):721-733
57. Naylor EW, Gardner EJ (1981) Adrenal adenomas in a patient with Gardner's syndrome. Clin Genet 20(1):67-73
58. Painter TA, Jagelman DG (1985) Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer 55(9):2001-2004
59. Tissier F et al (2005) Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65(17):7622-7627
60. Giordano TJ et al (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15(2):668-676
61. Berthon A et al (2010) Constitutive β-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum Mol Genet 19(8):1561-1576
62. Harada N et al (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18(21):5931-5942
63. Liu J et al (1995) H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 80(2):492-496
64. Giordano TJ et al (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162(2):521-531
65. West AN et al (2007) Gene expression profiling of childhood adrenocortical tumors. Cancer Res 67(2):600-608
66. Velazquez-Fernandez D et al (2005) Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138(6):1087-1094
67. Enklaar T et al (2006) Beckwith-Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med 8(17):1-19
68. Sun FL et al (1997) Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389(6653):809-815
69. Weber MM et al (1999) Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis. Endocrinology 140(4):1537-1543
70. Varrault A et al (2006) Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell 11(5):711-722
71. Barlaskar FM et al (2009) Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J Clin Endocrinol Metab 94(1):204-212
72. Haluska P et al (2009) Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. Cancer Chemother Pharmacol 65(4):765-773
73. Lu J et al (1998) Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech Dev 73(1):23-32
74. Quaggin SE et al (1998) Pod-1, a mesoderm-specific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney. Mech Dev 71(1-2):37-48
75. Cui S et al (2004) Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 131(16):4095-4105
76. Tamura M et al (2001) Pod-1/Capsulin shows a sex- and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP/SF-1. Mech Dev 102(1-2):135-144
77. Doghman M et al (2007) Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 21(12):2968-2987
78. Keegan CE et al (2005) Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator. Hum Mol Genet 14(1):113-123
79. Bianchi A, Shore D (2008) How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell 31(2):153-165
80. Deng Y et al (2008) Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 8(6):450-458
81. Ljungman M (2000) Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2(3):208-225
82. Else T (2009) Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis, and aging. J Mol Endocrinol 43(4):131-141
83. Dick JE (2008) Stem cell concepts renew cancer research. Blood 112(13):4793-4807
84. Goodell MA et al (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183(4):1797-1806
85. Lichtenauer UD, Beuschlein F (2009) The tumor stem cell concept-implications for endocrine tumors? Mol Cell Endocrinol 300(1-2):158-163
86. Hirschmann-Jax C et al (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101(39):14228-14233
87. Lichtenauer UD et al (2008) Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. Endocrinology 149(3):1314-1322